Compare $ATNM vs $ELUT | Chartloom

Compare

$ATNM vs $ELUT

Actinium Pharmaceuticals Inc · Elutia Inc

ATNM

Actinium Pharmaceuticals Inc

ELUT

Elutia Inc

Compare $ATNM vs $ELUT

Comparing Actinium Pharmaceuticals Inc and Elutia Inc

ATNMActinium Pharmaceuticals Inc

ELUTElutia Inc

ATNMActinium Pharmaceuticals Inc

Market cap

$35M

P/E (TTM)

3.06x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-19.7%

52W performance

-28.6%

FCF yield

-67.4%

ELUTElutia Inc

Market cap

$36M

P/E (TTM)

0.70x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-48.8%

YTD performance

28.0%

52W performance

-7.4%

FCF yield

-126.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATNM

ELUT

Detailed metrics comparison

ATNM

Actinium Pharmaceuticals Inc

ELUT

Elutia Inc

Market Cap

ATNM$35M

ELUT$36M

Enterprise Value

ATNM$-2M

ELUT$16M

Price

ATNM$1.10

ELUT$0.82

P/E Ratio

ATNM3.06x

ELUT0.70x

P/S Ratio

ATNM0.98x

ELUT3.00x

EV/Sales

ATNM-0.06x

ELUT1.36x

EV/EBITDA

ATNM-0.20x

ELUT0.00x

P/B Ratio

ATNM1.21x

ELUT2.19x

P/FCF Ratio

ATNMN/A

ELUTN/A

EV/FCF

ATNM0.08x

ELUT-0.36x

PEG Ratio

ATNMN/A

ELUTN/A

Forward P/E (NTM)

ATNMN/A

ELUTN/A

Forward P/S (NTM)

ATNMN/A

ELUTN/A

Revenue (TTM)

ATNM$35M

ELUT$12M

Revenue Growth (YoY)

ATNMN/A

ELUT-48.8%

Forward Rev Growth

ATNM-0.2%

ELUT-42.7%

Gross Margin (TTM)

ATNM0.0%

ELUT57.8%

Operating Margin (TTM)

ATNM62.3%

ELUT0.0%

EBITDA Margin (TTM)

ATNM27.9%

ELUT-163.0%

Net Margin (TTM)

ATNM32.2%

ELUT426.9%

FCF Margin (TTM)

ATNM-66.2%

ELUT-379.3%

Net Income (TTM)

ATNM$11M

ELUT$52M

FCF (TTM)

ATNM$-23M

ELUT$-46M

EPS (TTM)

ATNM$0.36

ELUT$1.17

ROE (TTM)

ATNM83.4%

ELUT253.3%

ROA (TTM)

ATNM23.4%

ELUT108.7%

ROIC (TTM)

ATNM83.4%

ELUT253.3%

Cash

ATNM$36M

ELUT$20M

Debt

ATNM$5K

ELUT$0

Net Cash/Debt

ATNM$36M

ELUT$20M

Current Ratio (TTM)

ATNM4.08x

ELUT1.77x

Quick Ratio (TTM)

ATNM3.94x

ELUT1.58x

Debt/Equity (TTM)

ATNM0.00x

ELUT0.00x

Debt/Assets (TTM)

ATNM0.0%

ELUT0.0%

Interest Coverage (TTM)

ATNMN/A

ELUTN/A

Net Debt/EBITDA (TTM)

ATNM0.00x

ELUT0.00x

Beta

ATNM0.33

ELUT0.97

52W Performance

ATNM-28.6%

ELUT-7.4%

YTD Performance

ATNM-19.7%

ELUT28.0%

% from 52W High

ATNM-36.8%

ELUT-40.6%

% from 52W Low

ATNM49.6%

ELUT64.6%

Asset Turnover (TTM)

ATNM0.73x

ELUT0.25x

FCF Yield (TTM)

ATNM-67.4%

ELUT-126.5%

Earnings Yield (TTM)

ATNM32.8%

ELUT142.4%

Dividend Yield (TTM)

ATNMN/A

ELUTN/A

Rule of 40

ATNM-66.2

ELUT-428.1

EV/GP/RG

ATNMN/A

ELUTN/A

Ticker research

View ATNM research View ELUT research

Metric	ATNM Actinium Pharmaceuticals Inc	ELUT Elutia Inc
Market & Valuation
Market Cap	$35M	$36M
Enterprise Value	$-2M	$16M
Price	$1.10	$0.82
P/E Ratio	3.06x	0.70x
P/S Ratio	0.98x	3.00x
EV/Sales	-0.06x	1.36x
EV/EBITDA	-0.20x	0.00x
P/B Ratio	1.21x	2.19x
P/FCF Ratio	N/A	N/A
EV/FCF	0.08x	-0.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$35M	$12M
Revenue Growth (YoY)	N/A	-48.8%
Forward Rev Growth	-0.2%	-42.7%
Profitability
Gross Margin (TTM)	0.0%	57.8%
Operating Margin (TTM)	62.3%	0.0%
EBITDA Margin (TTM)	27.9%	-163.0%
Net Margin (TTM)	32.2%	426.9%
FCF Margin (TTM)	-66.2%	-379.3%
Net Income (TTM)	$11M	$52M
FCF (TTM)	$-23M	$-46M
EPS (TTM)	$0.36	$1.17
ROE (TTM)	83.4%	253.3%
ROA (TTM)	23.4%	108.7%
ROIC (TTM)	83.4%	253.3%
Financial Health
Cash	$36M	$20M
Debt	$5K	$0
Net Cash/Debt	$36M	$20M
Current Ratio (TTM)	4.08x	1.77x
Quick Ratio (TTM)	3.94x	1.58x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.33	0.97
52W Performance	-28.6%	-7.4%
YTD Performance	-19.7%	28.0%
% from 52W High	-36.8%	-40.6%
% from 52W Low	49.6%	64.6%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.25x
FCF Yield (TTM)	-67.4%	-126.5%
Earnings Yield (TTM)	32.8%	142.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-66.2	-428.1
EV/GP/RG	N/A	N/A
Ticker research	View ATNM research	View ELUT research

Valuation

P/E Ratio

ELUT

0.70x

ATNM

3.06x

P/S Ratio

ATNM

0.98x

ELUT

3.00x

EV/FCF

ELUT

-0.36x

ATNM

0.08x

Growth & revenue

Revenue Growth TTM

ELUT

-48.8%

Forward Revenue Growth

ATNM

-0.2%

ELUT

-42.7%

Profitability & performance

Gross Margin

ELUT

57.8%

ATNM

0.0%

ROE

ELUT

253.3%

ATNM

83.4%

FCF Yield %

ATNM

-67.4%

ELUT

-126.5%

52-Week Performance

ELUT

-7.4%

ATNM

-28.6%

Detailed metrics comparison

ATNM

Actinium Pharmaceuticals Inc

ELUT

Elutia Inc

Market Cap

ATNM$35M

ELUT$36M

Enterprise Value

ATNM$-2M

ELUT$16M

Price

ATNM$1.10

ELUT$0.82

P/E Ratio

ATNM3.06x

ELUT0.70x

P/S Ratio

ATNM0.98x

ELUT3.00x

EV/Sales

ATNM-0.06x

ELUT1.36x

EV/EBITDA

ATNM-0.20x

ELUT0.00x

P/B Ratio

ATNM1.21x

ELUT2.19x

P/FCF Ratio

ATNMN/A

ELUTN/A

EV/FCF

ATNM0.08x

ELUT-0.36x

PEG Ratio

ATNMN/A

ELUTN/A

Forward P/E (NTM)

ATNMN/A

ELUTN/A

Forward P/S (NTM)

ATNMN/A

ELUTN/A

Revenue (TTM)

ATNM$35M

ELUT$12M

Revenue Growth (YoY)

ATNMN/A

ELUT-48.8%

Forward Rev Growth

ATNM-0.2%

ELUT-42.7%

Gross Margin (TTM)

ATNM0.0%

ELUT57.8%

Operating Margin (TTM)

ATNM62.3%

ELUT0.0%

EBITDA Margin (TTM)

ATNM27.9%

ELUT-163.0%

Net Margin (TTM)

ATNM32.2%

ELUT426.9%

FCF Margin (TTM)

ATNM-66.2%

ELUT-379.3%

Net Income (TTM)

ATNM$11M

ELUT$52M

FCF (TTM)

ATNM$-23M

ELUT$-46M

EPS (TTM)

ATNM$0.36

ELUT$1.17

ROE (TTM)

ATNM83.4%

ELUT253.3%

ROA (TTM)

ATNM23.4%

ELUT108.7%

ROIC (TTM)

ATNM83.4%

ELUT253.3%

Cash

ATNM$36M

ELUT$20M

Debt

ATNM$5K

ELUT$0

Net Cash/Debt

ATNM$36M

ELUT$20M

Current Ratio (TTM)

ATNM4.08x

ELUT1.77x

Quick Ratio (TTM)

ATNM3.94x

ELUT1.58x

Debt/Equity (TTM)

ATNM0.00x

ELUT0.00x

Debt/Assets (TTM)

ATNM0.0%

ELUT0.0%

Interest Coverage (TTM)

ATNMN/A

ELUTN/A

Net Debt/EBITDA (TTM)

ATNM0.00x

ELUT0.00x

Beta

ATNM0.33

ELUT0.97

52W Performance

ATNM-28.6%

ELUT-7.4%

YTD Performance

ATNM-19.7%

ELUT28.0%

% from 52W High

ATNM-36.8%

ELUT-40.6%

% from 52W Low

ATNM49.6%

ELUT64.6%

Asset Turnover (TTM)

ATNM0.73x

ELUT0.25x

FCF Yield (TTM)

ATNM-67.4%

ELUT-126.5%

Earnings Yield (TTM)

ATNM32.8%

ELUT142.4%

Dividend Yield (TTM)

ATNMN/A

ELUTN/A

Rule of 40

ATNM-66.2

ELUT-428.1

EV/GP/RG

ATNMN/A

ELUTN/A

Ticker research

View ATNM research View ELUT research

Metric	ATNM Actinium Pharmaceuticals Inc	ELUT Elutia Inc
Market & Valuation
Market Cap	$35M	$36M
Enterprise Value	$-2M	$16M
Price	$1.10	$0.82
P/E Ratio	3.06x	0.70x
P/S Ratio	0.98x	3.00x
EV/Sales	-0.06x	1.36x
EV/EBITDA	-0.20x	0.00x
P/B Ratio	1.21x	2.19x
P/FCF Ratio	N/A	N/A
EV/FCF	0.08x	-0.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$35M	$12M
Revenue Growth (YoY)	N/A	-48.8%
Forward Rev Growth	-0.2%	-42.7%
Profitability
Gross Margin (TTM)	0.0%	57.8%
Operating Margin (TTM)	62.3%	0.0%
EBITDA Margin (TTM)	27.9%	-163.0%
Net Margin (TTM)	32.2%	426.9%
FCF Margin (TTM)	-66.2%	-379.3%
Net Income (TTM)	$11M	$52M
FCF (TTM)	$-23M	$-46M
EPS (TTM)	$0.36	$1.17
ROE (TTM)	83.4%	253.3%
ROA (TTM)	23.4%	108.7%
ROIC (TTM)	83.4%	253.3%
Financial Health
Cash	$36M	$20M
Debt	$5K	$0
Net Cash/Debt	$36M	$20M
Current Ratio (TTM)	4.08x	1.77x
Quick Ratio (TTM)	3.94x	1.58x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.33	0.97
52W Performance	-28.6%	-7.4%
YTD Performance	-19.7%	28.0%
% from 52W High	-36.8%	-40.6%
% from 52W Low	49.6%	64.6%
Efficiency & Yields
Asset Turnover (TTM)	0.73x	0.25x
FCF Yield (TTM)	-67.4%	-126.5%
Earnings Yield (TTM)	32.8%	142.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-66.2	-428.1
EV/GP/RG	N/A	N/A
Ticker research	View ATNM research	View ELUT research